Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20009235 | 0.86 | CETP (0.40) | TSHRKMT2AMEN1MAOB | |
| SCHEMBL20012805 | 0.85 | MEN1 (0.48) | POLBKMT2AMEN1L3MBTL1ALDH1A1 | |
| SCHEMBL18775770 | 0.84 | TSHR (0.50) | TSHRKMT2AMEN1L3MBTL1ALDH1A1 | |
| SCHEMBL19967702 | 0.77 | ABL1 (0.36) | KMT2AMEN1 | |
| SCHEMBL21287013 | 0.75 | ALDH1A1 (0.44) | POLBKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL10792593 | 0.74 | TSHR (0.67) | CTBP2POLBTSHRKMT2AMEN1 | |
| SCHEMBL11553441 | 0.73 | CTBP2 (0.56) | CTBP2POLBKMT2AL3MBTL1MAOB | |
| SCHEMBL18775940 | 0.73 | NLRP3 (0.34) | POLBTSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL24452995 | 0.71 | MGLL (0.33) | TSHR | |
| SCHEMBL18775773 | 0.71 | TDP1 (0.41) | KMT2AL3MBTL1ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086948-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT | SLC9A1, FN1, EPCAM | CTBP2 2434/4885POLB 3653/4885TSHR 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.